A framework to guide dose & regimen strategy for clinical drug development

Optimizing new drug therapies remains a challenge for clinical development, despite the use of ever more sophisticated quantitative methodologies. Although conceptually simple, the idea of finding the right treatment at the right dose for the right patient to ensure an appropriate balance of risks a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sander, Oliver, Magnusson, Baldur, Ludwig, Inga, Jullion, Astrid, Meille, Christophe, Lorand, Daniel, Bornkamp, Björn, Hinder, Markus, Kovacs, Steven J., Looby, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592517/
https://www.ncbi.nlm.nih.gov/pubmed/34562310
http://dx.doi.org/10.1002/psp4.12701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592517/
https://www.ncbi.nlm.nih.gov/pubmed/34562310
http://dx.doi.org/10.1002/psp4.12701

Ejemplares similares